Mark C. Bronfman – Trademark Portfolio

Entity Type: 01

Mark C. Bronfman holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SELL·PAY·CONVEY and HARMONIZING CAPITAL...EMPOWERING LIVES. The owner is based in Bethesda, MD.

8101 Glenmore Spring Road

Bethesda, MD 20817

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Mark C. Bronfman's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (2 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Mark C. Bronfman have?

Mark C. Bronfman has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Mark C. Bronfman file in?

Mark C. Bronfman files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Mark C. Bronfman's most well-known trademarks?

Mark C. Bronfman's registered trademark portfolio includes well-known marks such as SELL·PAY·CONVEY and HARMONIZING CAPITAL...EMPOWERING LIVES. These are among 2 currently registered trademarks in the portfolio.

What is Mark C. Bronfman's trademark registration success rate?

Mark C. Bronfman has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.